PER 3.85% 13.5¢ percheron therapeutics limited

Meanwhile back at the ranch... Sarepta CEO has just purchased...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,698 Posts.
    lightbulb Created with Sketch. 1093
    Meanwhile back at the ranch...

    Sarepta CEO has just purchased $2m of stock on market.

    Confidence right there ladies and gentlemen.....and non-binaries!  

    Doug now needs to figure out how to spend that US$2B in cash.
    _________________

    This from Nov 19th.

    Those following along with Sarepta Therapeutics, Inc. (NASDAQ:SRPT) will no doubt be intrigued by the recent purchase of shares by Douglas Ingram, President of the company, who spent a stonking US$2.0m on stock at an average price of US$79.94. While that only increased their holding size by 7.4%, it is still a big swing by our standards.
    .
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.